Samsung Seoul Hospital Becomes First in Korea to Perform Dual-Energy Ablation

Utilizing Both Radiofrequency and Pulsed Field Energies with a Single Catheter
Tailored Arrhythmia Treatment Strategies According to Cardiac Wall Thickness
On Younggeun: "Personalized Therapies Now Possible for Each Patient"

Samsung Seoul Hospital announced on October 7 that it has become the first in Korea to perform dual-energy ablation (DEA), a procedure for atrial fibrillation treatment that utilizes both radiofrequency (RF) and pulsed field (PF) energies together.

Professor On Younggeun of Samsung Medical Center is performing Dual-Energy Ablation (DEA). Samsung Medical Center

DEA is an arrhythmia treatment that allows both pulsed field ablation and radiofrequency ablation to be performed using a single catheter. Its key feature is that the most appropriate energy can be selected according to the patient's condition and the area being treated.

For instance, when treating the heart wall close to the esophagus or phrenic nerve, pulsed field ablation is used as it poses relatively less risk of damaging surrounding tissues. If energy needs to be delivered to thick or deep cardiac tissue, radiofrequency ablation is employed instead.

On Younggeun, Director of the Arrhythmia Center and Professor of Cardiology at Samsung Seoul Hospital, stated, "By combining traditional RFA and next-generation PFA, we can now establish more flexible and individualized treatment strategies for patients. We will continue to drive innovation in arrhythmia therapies and strive to deliver an even better treatment experience for our patients."

This content was produced with the assistance of AI translation services.